EUCTR2010-019981-94-FI
Active, Not Recruiting
N/A
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapy
HUS/ Neuropsykiatrian poliklinikka0 sites30 target enrollmentJuly 23, 2010
ConditionsPatients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.MedDRA version: 12.1Level: LLTClassification code 10064104Term: ADHD
DrugsStrattera
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Patients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.
- Sponsor
- HUS/ Neuropsykiatrian poliklinikka
- Enrollment
- 30
- Status
- Active, Not Recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Study inclusion requires patients to meet DSM\-IV criteria for ADHD in childhood and adulthood as well as opioid dependence. Patients must have been committed to opioid maintenance therapy for at least six months prior to study entry.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) no
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Exclusion criteria are an unstable medical or psychiatric condition, pregnancy and nursing or a known sensitivity to atomoxetine.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
erofeeback Training (NFT) of ADHD child at homeADHDADHD hyperactiveD046650JPRN-jRCT1030220201Tazaki Miyako8
Completed
N/A
Attention deficit hyperactivity disorder, developmental coordination disorder, and the cognitive orientation to daily occupational performance approach: Is there a role for diagnostic profiling and treatment to improve mental health outcomes?Attention Deficit Hyperactivity DisorderDevelopmental Coordination DisorderMental Health - Other mental health disordersPhysical Medicine / Rehabilitation - Occupational therapyACTRN12618001972213a Trobe University19
Not Yet Recruiting
Phase 3
Identification of Attention Deficit Hyperactivity Disorder using Parent-Teacher administered ADHD Rating Scale-IV among Pre-school going children to know the prevalence of this disorder in Belagavi city.CTRI/2023/07/054991KAHER Institute Of Physiotherapy
Recruiting
Phase 2
Attention Defficity Hyperactivity Disorder and fMRI neurofeedback: A randomized controlled trial on the effects of self-modulating anterior cingulate cortex activation levels.NL-OMON37512niversitair Medisch Centrum Sint Radboud
Completed
Phase 3
Imaging the influence and interaction of genes and stimulant medication on attention in Attention Deficit Hyperactivity Disorder (ADHD).ACTRN12610000652077Dr. Tim Silk36